Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement

doi:10.1371/journal.pmed.1000420

Guideline

. 2011 Mar;8(3):e1000420.

doi: 10.1371/journal.pmed.1000420. Epub 2011 Mar 15.

Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement

A Cecile J W Janssens¹, John P A Ioannidis, Cornelia M van Duijn, Julian Little, Muin J Khoury; GRIPS Group

Collaborators, Affiliations

Affiliation

¹ Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands. a.janssens@erasmusmc.nl

PMID: 21423587
PMCID: PMC3058100
DOI: 10.1371/journal.pmed.1000420

Guideline

Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement

A Cecile J W Janssens et al. PLoS Med. 2011 Mar.

. 2011 Mar;8(3):e1000420.

doi: 10.1371/journal.pmed.1000420. Epub 2011 Mar 15.

Authors

A Cecile J W Janssens¹, John P A Ioannidis, Cornelia M van Duijn, Julian Little, Muin J Khoury; GRIPS Group

Affiliation

¹ Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands. a.janssens@erasmusmc.nl

PMID: 21423587
PMCID: PMC3058100
DOI: 10.1371/journal.pmed.1000420

Abstract

Cecile Janssens and colleagues present the GRIPS Statement, a checklist to help strengthen the reporting of genetic risk prediction studies.

PubMed Disclaimer

Conflict of interest statement

John P. A. Ioannidis is a member of the PLoS Medicine Editorial Board.

Cited by

BDNF Genetic Variant and Its Genotypic Fluctuation in Major Depressive Disorder.
Ferreira Fratelli C, Willatan Siqueira J, Rodrigues Gontijo B, de Lima Santos M, de Souza Silva CM, Rodrigues da Silva IC. Ferreira Fratelli C, et al. Behav Neurol. 2021 Nov 1;2021:7117613. doi: 10.1155/2021/7117613. eCollection 2021. Behav Neurol. 2021. PMID: 34760029 Free PMC article.
The Influence of Beta-2 Adrenergic Receptor Gene Polymorphisms on Albuterol Therapy for Patients With Asthma: Protocol for a Systematic Review and Meta-Analysis.
Hikino K, Kobayashi S, Ota E, Mushiroda T, Kobayashi T. Hikino K, et al. JMIR Res Protoc. 2019 Sep 16;8(9):e14759. doi: 10.2196/14759. JMIR Res Protoc. 2019. PMID: 31538939 Free PMC article.
Better reporting of scientific studies: why it matters.
PLOS Medicine Editors. PLOS Medicine Editors. PLoS Med. 2013 Aug;10(8):e1001504. doi: 10.1371/journal.pmed.1001504. Epub 2013 Aug 27. PLoS Med. 2013. PMID: 24013839 Free PMC article.
A systems genetics approach provides a bridge from discovered genetic variants to biological pathways in rheumatoid arthritis.
Nakaoka H, Cui T, Tajima A, Oka A, Mitsunaga S, Kashiwase K, Homma Y, Sato S, Suzuki Y, Inoko H, Inoue I. Nakaoka H, et al. PLoS One. 2011;6(9):e25389. doi: 10.1371/journal.pone.0025389. Epub 2011 Sep 28. PLoS One. 2011. PMID: 21980439 Free PMC article.
Environmental risk score as a new tool to examine multi-pollutants in epidemiologic research: an example from the NHANES study using serum lipid levels.
Park SK, Tao Y, Meeker JD, Harlow SD, Mukherjee B. Park SK, et al. PLoS One. 2014 Jun 5;9(6):e98632. doi: 10.1371/journal.pone.0098632. eCollection 2014. PLoS One. 2014. PMID: 24901996 Free PMC article.

See all "Cited by" articles

References

1. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007;9:665–674. - PubMed
1. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119:2408–2416. - PMC - PubMed
1. Kyzas PA, Denaxa-Kyza D, Ioannidis JP. Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect. J Natl Cancer Inst. 2007;99:236–243. - PubMed
1. Kyzas PA, Loizou KT, Ioannidis JP. Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst. 2005;97:1043–1055. - PubMed
1. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, et al. REporting recommendations for tumor MARKer prognostic studies (REMARK). Nat Clin Pract Urol. 2005;2:416–422. - PubMed

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

UL1 RR025752/RR/NCRR NIH HHS/United States

LinkOut - more resources

Full Text Sources

[1] Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007;9:665–674. - PubMed

[2] Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007;9:665–674. - PubMed

[3] Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119:2408–2416. - PMC - PubMed

[4] Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119:2408–2416. - PMC - PubMed

[5] Kyzas PA, Denaxa-Kyza D, Ioannidis JP. Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect. J Natl Cancer Inst. 2007;99:236–243. - PubMed

[6] Kyzas PA, Denaxa-Kyza D, Ioannidis JP. Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect. J Natl Cancer Inst. 2007;99:236–243. - PubMed

[7] Kyzas PA, Loizou KT, Ioannidis JP. Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst. 2005;97:1043–1055. - PubMed

[8] Kyzas PA, Loizou KT, Ioannidis JP. Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst. 2005;97:1043–1055. - PubMed

[9] McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, et al. REporting recommendations for tumor MARKer prognostic studies (REMARK). Nat Clin Pract Urol. 2005;2:416–422. - PubMed

[10] McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, et al. REporting recommendations for tumor MARKer prognostic studies (REMARK). Nat Clin Pract Urol. 2005;2:416–422. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement

Collaborators

Affiliation

Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement

Authors

Collaborators

Affiliation

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources